18934-70-8

Basic information

• Product Name: L-Phenylalanine, 1-methylethyl ester
• Synonyms: (S)-2-Amino-3-phenyl-propionic acid isopropyl ester;Phe-OiPr;isopropyl (L)-phenylalanine;L-phenylalanine isopropyl ester;L-Phenylalanin-isopropylester;Phenylalanin-isopropylester
• CAS NO: 18934-70-8
• Molecular Formula: C12H17NO2
• Molecular Weight: 207.272
• Mol File: 18934-70-8.mol
• Article Data: 15

Chemical Properties

• CAS DataBase Reference: L-Phenylalanine, 1-methylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: L-Phenylalanine, 1-methylethyl ester(18934-70-8)
• EPA Substance Registry System: L-Phenylalanine, 1-methylethyl ester(18934-70-8)

Safety Data

• Hazardous Substances Data: 18934-70-8(Hazardous Substances Data)

Upstream product

• 63-91-2 L-phenylalanine 
• 67-63-0 isopropyl alcohol 
• 2577-90-4 methyl (2S)-2-amino-3-phenylpropanoate 
• 35016-63-8 (S)-2-bromo-3-phenylpropionic acid 
• 116911-32-1 (S)-2-azido-3-phenylpropionic acid methyl ester 
• 124916-61-6 (S)-2-bromo-3-penylpropanoic acid methyl ester 
• 150-30-1 Phenylalanine 

Downstream Products

• 97800-64-1 (Me)2Val-Phe-OiPr 
• 97800-66-3 (Me)2Phe-Phe-OiPr 
• 57744-87-3 3-Phenyl-2-(2,2,2-trifluoro-acetylamino)-propionic acid isopropyl ester 
• 179324-69-7 velcade 
• 114457-94-2 (S)-3-phenyl-2[(pyrazine-2-carbonyl)-amino]propionic acid 

Relevant articles and documents

PROCESS FOR PREPARING BORTEZOMIB, INTERMEDIATES, AND CRYSTALLINE FORMS THEREOF

The present disclosure provides a process for preparing Bortezomib, intermediates, and crystalline forms thereof.

LIVER PRODRUGS OF MITOCHONDRIAL PROTON IONOPHORES

The present invention provides novel liver-targeted prodrugs of mitochondrial proton ionophores. These compounds have utility in medicine including their use in treatment of diseases such as NASH and NAFLD.

COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTIONS

Provided herein are compounds, compositions and methods for the treatment of liver disorders, including HCV infections. In one embodiment, compounds and compositions of nucleoside derivatives are disclosed, which can be administered either alone or in com